DLIMI is now Signum


Guidance for meeting legal requirements

Tell authorities what they want to know

It’s important to have as much knowledge as possible when venturing into new areas of expertise. Signum can give you the guidance you need to plan your analyses, so you can get as much value as possible from them.

Look through a different lens

Public authorities increasingly demand treatment impact documentation from real-world studies. Getting that information to them isn’t as easy as one would expect. Signum can help you see your documentation from the authorities’ perspective to ensure that you follow the process and include all the information they require. 

Is the study worth it?
Is this study worth the effort? We get that question a lot, and sometimes the answer is “no”. To determine your study’s worth, you need to understand how authorities think and which kind of documentation they consider relevant and valuable. Having that understanding will give you the best starting point for your analyses.

At Signum, we understand the dynamics between the pharmaceutical industry, decisionmakers and legal authorities. We will help you learn why and how to conduct a real-world study and how to determine if that study is worth the effort, so that you can focus on what really matters.


  • Knowledge of industry dynamics
  • Experience with authorities’ requirements
  • Experts in data-driven insights and computer science


  • Wise prioritisation of resources
  • Alignment with expectations from authorities
  • Clarity on the purpose and focus of the study

Strengthen your position

  • Impact your own position with relevant data
  • Avoid dead-ends and too much nice-to-know information
  • Make a difference for patients, decisionmakers and other stakeholders

For more information, please contact

Andreas Bentsen, employee at Signum, Chief Advisor Team Lead Real World Evidence

Andreas Høiberg Bentsen

Chief Advisor, Team Lead Real World Evidence


+45 40 389 954